首页 | 本学科首页   官方微博 | 高级检索  
检索        

肾康注射液治疗慢性肾脏病4期的临床研究
引用本文:霍延红,王亚平,张文博,杨永红,李浩,王彩霞.肾康注射液治疗慢性肾脏病4期的临床研究[J].中国医药导刊,2012,14(7):1191+1193.
作者姓名:霍延红  王亚平  张文博  杨永红  李浩  王彩霞
作者单位:北京军区总医院北京军区肾脏病诊断治疗中心,北京,100700
摘    要:目的:探讨肾康注射液治疗慢性肾脏病4期(CKD4)的临床效果。方法:分析我院收治的慢性肾脏病4期患者临床资料,依据治疗方式不同分为观察组(肾康注射液治疗组)60例和对照组(常规治疗组)30例。结果:观察组Scr、BUN、RBC、Hb、GFR均优于对照组,同时通过临床疗效评价,观察组临床治疗总有效率明显优于对照组,P<0.05,差异均有统计学意义。结论:肾康注射液治疗慢性肾脏病4期临床症状改善明显,效果显著,值得临床借鉴应用。

关 键 词:肾康注射液  慢性肾脏病4期  疗效

The Clinical Research of Curing Chronic Kidney Disease Four Periodicals by Shenkang Injection
Institution:Huo Yan-hong,Wang Ya-ping,Zhang Wen-bo,et al.(Center of Diagnosis and Treatment Kidney Disease of Beijing PLA,General Hospital of Beijing Military Army,Beijing 100700,China)
Abstract:Objective:To approach clinical result of curing chronic kidney disease four periodicals by shenkang injection.Methods:To analyze clinical data of curing chronic kidney disease four periodicals,which was to be divided into detection group(shenkang injection curing group)60 cases and control group(conventional treatment group)30 cases.Results:The Scr、BUN、RBC、Hb、GFR of detection group were better than control group,then the clinical curative effect evaluation,clinical treatment of total efficiency of detection group was better than control group,P<0.05,the difference were statistical significance.Conclusion:The clinical symptoms improved significantly of curing chronic kidney disease four periodicals by shenkang injection,the result was obviously,which was to be used.
Keywords:Shenkang injection  Chronic kidney disease four periodicals  curative effect
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号